Delivery Order SPE2DB24D9222-SPE2DB24FAZHD

Award Date 9/18/24
Potential Completion Date 10/9/24
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,691.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4565781429 RITUXAN 500 MG/50 ML VIAL 50ML to DLA's Medical Supply Chain division. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,227.00 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, with a period of performance ending on November 18, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award, valued at $12,276.68, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4566185182 - RITUXAN 500 MG/50 ML VIAL 50ML. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a Firm Fixed Price Delivery Order valued at $41,649.97, is for the supply of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,247.48 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,931.76 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, and has an ultimate completion date of May 19, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,138.34 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, and is not set aside for any specific business category. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,187.29 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, a biologic medication. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. This single-award...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The $15,345.85 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, with a completion date of March 5, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to provide a wide range of pharmaceutical products to military health...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,276.68 contract is for the supply of Rituxan 500 mg/50 ml vial, a pharmaceutical product used for medical treatment. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive...
  • SPE2DB24D9222
    Indefinite Delivery Contract
  • SPE2DB24D9222-SPE2DB24FAZHD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,207.51, is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support the medical supply needs of the U.S. Department of Defense (DoD) healthcare facilities. The contract is a firm fixed-price delivery order with no set-aside designation, and it has an ultimate completion date of October 9, 2024.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both common medications and specialized drugs, to fulfill the recurring medical supply needs of military health facilities worldwide.

Generated 12/18/24, 9:16 AM